Pressmeddelanden, rapporter och bolagsmeddelande för Dancann Pharma
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S announces outcome of the Rights Issue
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S announces outcome of the Rights Issue
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Last day of subscription of shares in the ongoing Rights Issue is 20 June 2024 on Nordnet Bank and Avanza Bank
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Solid growth in the Rx portfolio
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Germany trends – prescriptions for medicinal cannabis positively influenced by new legalization
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Submits applications for FLS03 and FLS04 to expand portfolio
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: The subscription period of DanCann Pharma’s Rights Issue begins today
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Publishes Q1-2024 Report
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Minutes OF ANNUAL GENERAL MEETING
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: The Board of Directors has resolved on a partially (48.88 percent) secured Rights Issue of approximately DKK 18.33 million and publishes memorandum